Palomar Medical Tech (PMTI) Posts Wider than Expected Q3 Loss of 25c/Sh.

Palomar Medical Tech (NASDAQ: PMTI) reported Q3 EPS of ($0.25), $0.19 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.48 million versus the consensus estimate of $19.4 million.

For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Surf Air Mobility names Palantir veteran as president of SurfOS
• CarMax (KMX) PT Raised to $47 at Morgan Stanley